Clinical Trials Sponsored by Perrigo Company

Total 6139 results

Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions

Bioavailability
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions

Bioequivalency
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions

Bioequivalency
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions

Bioequivalency
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions

Bioequivalency
Perrigo Company

Completed

Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions

Bioavailability
University of Texas at Austin
Perrigo Company

Not yet recruiting

Interventions to Manage Food Insecurity and Inappropriate Feeding Practices Related to the COVID-19 Pandemic (AMISTAD)

Covid19 | Food Insecurity | Children, Only

United States
Tel-Aviv Sourasky Medical Center
Perrigo Company

Unknown

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

Breast Cancer | Osteoporosis, Osteopenia
Perrigo CSCI

Recruiting

Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation

Head Lice

Mauritius
Perrigo CSCI

Recruiting

Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation

Head Lice Infestation

Mauritius
Perrigo Nutritionals

Completed

Formula for Children With Cow's Milk Allergy

Milk Allergy

United States
Perrigo Nutritionals

Completed

Tolerability and Safety of An Infant Formula

Milk Hypersensitivity
Perrigo Nutritionals

Completed

Growth and Safety of a Low Lactose Milk-Based Infant Formula

Growth | Healthy Term Infants

United States
Perrigo Nutritionals

Completed

Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term

Growth

United States
Perrigo CSCI
Analyze & Realize

Recruiting

Effects of Arterin Cholesterol for Reduction of Lipid Levels

Blood Cholesterol Lowers | LDL-C

Germany
Perrigo CSCI
Analyze & Realize

Completed

DBRPC Study to Evaluate the Efficacy and Safety of IQP-AE-103 in Overweight and Moderately Obese Subjects

Obesity | Overweight

Germany
Perrigo Company
GlaxoSmithKline; Pfizer; McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. and other collaborators

Completed

A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold

Nasal Congestion Associated With the Common Cold

United States
Centre Jean Perrin

Recruiting

Impact of Implementing the Modified A-DIVA Scale on Successful Access to a Venous Line on the First Attempt (DIVAPERF)

Chronic Disease

France
Centre Jean Perrin

Recruiting

Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients (INSTIGO)

Triple Negative Breast Cancer

France
Centre Jean Perrin

Recruiting

Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer (XenoBreast)

Breast Cancer Female

France
Centre Jean Perrin

Recruiting

Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients (PERCEPTION)

Triple Negative Breast Cancer

France
Centre Jean Perrin

Completed

Breast Localization: RFID Tags vs Wire Localization (RFID)

Breast Neoplasm Female

France
Centre Jean Perrin

Completed

Loreline Study: Characterization of Long Responders Under Eribuline (Loreline)

Breast Cancer Patients | Therapy Related Tumor

France
Centre Jean Perrin

Completed

Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer (IriGen)

First Line Metastatic Colorectal Cancer

France
Centre Jean Perrin

Completed

ROPI Study : Ropivacaine Interest in Postsurgical Pain After Mastectomy (ROPI)

Pain After Mastectomy

France
Centre Jean Perrin

Terminated

Adaptated Physical Activity in Cancerology (APACAN)

Breast Cancer
Centre Jean Perrin

Terminated

Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity Search

Mammary Tumor

France
Centre Jean Perrin

Recruiting

Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012 (MELRIV-1)

Melanoma

France
Centre Jean Perrin

Recruiting

Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer (Rexochir)

Lungcancer

France
Centre Jean Perrin

Completed

Impact of Chemo-induced Menopause on Quality of Life in Women <45 Years Old, Diagnosed With Non-metastatic Breast Cancer (MENOCOR)

BREAST CANCER

France
Centre Jean Perrin

Completed

Satisfaction Assessment of Patients With Local Breast Cancer When Using Cosmetics During Chemotherapy and Post-treatment Thermal Cure (COSMIK)

Local Breast Cancer Patients

France
Centre Jean Perrin

Terminated

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes

Metastatic Breast Cancer

France
Centre Jean Perrin

Terminated

Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib (ProMETheX)

Colorectal Cancer | Metastatic Breast Cancer

France
Centre Jean Perrin

Completed

Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients (CILOVE)

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

France
Centre Jean Perrin

Terminated

Support and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After Chemotherapy

Non Metastatic Breast Cancer

France
Centre Jean Perrin

Terminated

Ultrasound-guided PVB (BPV échoguidé)

Anesthesia | Post-operative Pain | Thoracotomy Surgery | Ultrasound-guided PVB

France
Centre Jean Perrin

Completed

Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer (PROTAXY)

Metastatic Prostate Cancer

France
Centre Jean Perrin

Recruiting

Adapted Physical Activity for Breast Cancer HER2 Positive Patient (APACAN2)

HER2 Positive Breast Cancer

France
Centre Jean Perrin

Completed

Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer (CARSPECT)

Breast Cancer | Osteoarthritis, Knee

France
Centre Jean Perrin

Terminated

Impact of a Melatonin Supplementation on the Quality of Life in Elderly Metastatic Cancer Patients (MEQAPAG)

Cancer

France
Centre Jean Perrin

Completed

Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2) (MetaCa2)

Breast Cancer | Hormonal Therapy

France
Centre Jean Perrin

Terminated

Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer

Breast Cancer

France
Centre Jean Perrin

Terminated

Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL) (CURTAXEL)

Prostate Cancer Metastatic Castration Resistant

France
Centre Jean Perrin

Withdrawn

Efficacy Assessment of CT-guided Hook Wire Localization of Lung Nodes Before Thoracoscopy (HARNO)

Nodes, Lung

France
Centre Jean Perrin

Completed

Hemodynamic Repercussions of the Correction (Surgical and Non Surgical) of Pectus Excavatum-type Thoracic Deformities (PECTUS)

Pectus Excavatum

France
Centre Jean Perrin

Withdrawn

Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin (ISOTOVE)

Ovarian Cancer

France
Centre Jean Perrin

Terminated

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes (META2)

Metastatic Breast Cancer

France
Centre Jean Perrin

Completed

Weight Variation During Chemotherapy in Breast Cancer Patients

Breast Cancer

France
Centre Jean Perrin

Completed

Breast Cancer Treated by Neoadjuvant Chemotherapy

Individualized Chemotherapy

France
Centre Jean Perrin

Completed

Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer. (TVA)

Pathological Response Rate

France

3

Subscribe